Medicare Enrolled

Dr. Mohsen Tabrizi, MD

Endocrinology · Long Beach, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3300 E SOUTH STREET, Long Beach, CA 90805
5626349803
In practice since 2008 (17 years)
NPI: 1093973760 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tabrizi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tabrizi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tabrizi

Dr. Mohsen Tabrizi is an endocrinology specialist in Long Beach, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Tabrizi performed 1,325 Medicare services across 508 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tabrizi received a total of $6,420 from 42 pharmaceutical and/or device companies across 393 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tabrizi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 37% volume in CA $6,420 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,325
Medicare services
Top 37% in CA for endocrinology
508
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~78 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
674 $67 $130
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
449 $98 $150
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
97 $111 $350
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
61 $27 $60
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
44 $136 $320
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,420
Total received (2018-2024)
Avg $917/year across 7 years
Top 26% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
393
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,420 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,079
2023
$1,001
2022
$826
2021
$919
2020
$849
2019
$1,033
2018
$714

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$406
Dexcom, Inc.
$158
Abbott Laboratories
$144
Novo Nordisk Inc
$64
Tandem Diabetes Care, Inc.
$63
ABBVIE INC.
$33
RECORDATI_RARE_DISEASES_INC.
$33
Amgen Inc.
$30
Mannkind Corporation
$29
Madrigal Pharmaceuticals
$28
Corcept Therapeutics
$27
Ascensia Diabetes Care Us Inc.
$23
Medtronic, Inc.
$14
CeQur Corporation
$14
Radius Health, Inc.
$14
Top 3 companies account for 65.6% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$1,747
Novo Nordisk Inc
$737
Mannkind Corporation
$494
Abbott Laboratories
$421
Dexcom, Inc.
$394
SANOFI-AVENTIS U.S. LLC
$265
Amarin Pharma Inc.
$254
MannKind Corporation
$205
LifeScan, Inc.
$147
AstraZeneca Pharmaceuticals LP
$131
Corcept Therapeutics
$129
Radius Health, Inc.
$114
Becton, Dickinson and Company
$104
Insulet Corporation
$98
Amgen Inc.
$96
Medtronic MiniMed, Inc.
$72
Ascensia Diabetes Care Us Inc.
$70
Medtronic, Inc.
$66
CeQur Corporation
$64
Tandem Diabetes Care, Inc.
$63
ABBVIE INC.
$59
RECORDATI_RARE_DISEASES_INC.
$57
Alvogen Inc
$55
AbbVie Inc.
$52
Xeris Pharmaceuticals, Inc.
$49
Zealand Pharma US, Inc.
$46
LIFESCAN, INC.
$45
Antares Pharma, Inc.
$45
Merck Sharp & Dohme Corporation
$41
Janssen Pharmaceuticals, Inc
$37
IBSA Pharma Inc.
$30
Ascensia Diabetes Care US Inc.
$30
Madrigal Pharmaceuticals
$28
Alexion Pharmaceuticals, Inc.
$24
Esperion Therapeutics, Inc.
$23
Bigfoot Biomedical Inc
$22
Shire North American Group Inc
$21
Nevro Corp.
$21
Amryt Pharma Holdings Ltd
$19
GlaxoSmithKline, LLC.
$18
PFIZER INC.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$11
Top 3 companies account for 46.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · ANORO ELLIPTA · APIDRA · BAQSIMI · BASAGLAR · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · CeQur Simplicity · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE PFS · HUMALOG · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · JANUVIA · JARDIANCE · Korlym · LYUMJEV · Levemir · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 530G · Minimed 670G System · NATPARA · NEXLETOL · ONETOUCH VERIO REFLECT · OT Verio Flex Starter Kit · OT Verio Reflect "One Touch Meter and Strips" · Omnia · Omnipod · OneTouch · OneTouch Verio Reflect · Otrexup · Ozempic · RESMETIROM · RYBELSUS · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · SYNTHROID · Saxenda · Strensiq · TALTZ · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tymlos · UNITY DIABETES MANAGEMENT SYSTEM · Vascepa · Victoza · Wegovy · XYOSTED · ZEGALOGUE · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Long Beach?
Compare endocrinologists in the Long Beach area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
298
Per 100K population
3.0
County median income
$87,760
Nearest hospital
UCI HEALTH-LAKEWOOD
2.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Tabrizi is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Tabrizi experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Tabrizi performed 674 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tabrizi receive payments from pharmaceutical companies?
Yes. Dr. Tabrizi received a total of $6,420 from 42 companies across 393 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tabrizi's costs compare to other endocrinologists in Long Beach?
Dr. Tabrizi's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tabrizi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →